BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Reilly JP, Calfee CS, Christie JD. Acute Respiratory Distress Syndrome Phenotypes. Semin Respir Crit Care Med 2019;40:19-30. [PMID: 31060085 DOI: 10.1055/s-0039-1684049] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Radbel J, Laskin DL, Laskin JD, Kipen HM. Disease-modifying treatment of chemical threat agent-induced acute lung injury. Ann N Y Acad Sci 2020;1480:14-29. [PMID: 32726497 DOI: 10.1111/nyas.14438] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Pal N, Kertai MD. Perioperative Precision Medicine: Where Are We in 2020? Curr Opin Anaesthesiol 2020;33:463-74. [PMID: 32371636 DOI: 10.1097/ACO.0000000000000858] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Kotas ME, Thompson BT. Toward Optimal Acute Respiratory Distress Syndrome Outcomes: Recognizing the Syndrome and Identifying Its Causes. Crit Care Clin 2021;37:733-48. [PMID: 34548131 DOI: 10.1016/j.ccc.2021.05.011] [Reference Citation Analysis]
4 Xu G, Wan H, Yi L, Chen W, Luo Y, Huang Y, Liu X. Berberine administrated with different routes attenuates inhaled LPS-induced acute respiratory distress syndrome through TLR4/NF-κB and JAK2/STAT3 inhibition. Eur J Pharmacol 2021;908:174349. [PMID: 34284014 DOI: 10.1016/j.ejphar.2021.174349] [Reference Citation Analysis]
5 Nakashima S, Miyamoto A, Takahashi Y, Nakahama H, Moriguchi S, Murase K, Morokawa N, Daiya T. Mendelson's syndrome complicated by bacterial aspiration pneumonia triggered by right putamen bleeding: A case report. Respir Med Case Rep 2021;33:101466. [PMID: 34401302 DOI: 10.1016/j.rmcr.2021.101466] [Reference Citation Analysis]
6 Dembinski R. [Is it really an acute respiratory distress syndrome? : Current definitions, pathophysiology and differentiated diagnoses]. Anaesthesist 2020;69:439-50. [PMID: 32430536 DOI: 10.1007/s00101-020-00789-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Bloomfield R, Noble DW, Sudlow A. Prone position for acute respiratory failure in adults. Cochrane Database Syst Rev. 2015;11:CD008095. [PMID: 26561745 DOI: 10.1002/14651858.cd008095.pub2] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 5.7] [Reference Citation Analysis]
8 Surolia R, Li FJ, Wang Z, Kashyap M, Srivastava RK, Traylor AM, Singh P, Dsouza KG, Kim H, Pittet JF, Zmijewski JW, Agarwal A, Athar M, Ahmad A, Antony VB. NETosis in the pathogenesis of acute lung injury following cutaneous chemical burns. JCI Insight 2021;6:147564. [PMID: 34027893 DOI: 10.1172/jci.insight.147564] [Reference Citation Analysis]
9 Zebialowicz Ahlström J, Massaro F, Mikolka P, Feinstein R, Perchiazzi G, Basabe-Burgos O, Curstedt T, Larsson A, Johansson J, Rising A. Synthetic surfactant with a recombinant surfactant protein C analogue improves lung function and attenuates inflammation in a model of acute respiratory distress syndrome in adult rabbits. Respir Res 2019;20:245. [PMID: 31694668 DOI: 10.1186/s12931-019-1220-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
10 Liu X, Jiang Y, Jia X, Ma X, Han C, Guo N, Peng Y, Liu H, Ju Y, Luo X, Li X, Bu Y, Zhang J, Liu Y, Gao Y, Zhao M, Wang H, Luo L, Yu K, Wang C. Identification of distinct clinical phenotypes of acute respiratory distress syndrome with differential responses to treatment. Crit Care 2021;25:320. [PMID: 34461969 DOI: 10.1186/s13054-021-03734-y] [Reference Citation Analysis]
11 Rolandsson Enes S, Krasnodembskaya AD, English K, Dos Santos CC, Weiss DJ. Research Progress on Strategies that can Enhance the Therapeutic Benefits of Mesenchymal Stromal Cells in Respiratory Diseases With a Specific Focus on Acute Respiratory Distress Syndrome and Other Inflammatory Lung Diseases. Front Pharmacol 2021;12:647652. [PMID: 33953680 DOI: 10.3389/fphar.2021.647652] [Reference Citation Analysis]
12 Rich TC, Leavesley SJ, Brandon AP, Evans CA, Raju SV, Wagener BM. Phosphodiesterase 4 mediates interleukin-8-induced heterologous desensitization of the β2 -adrenergic receptor. FASEB J 2021;35:e21946. [PMID: 34555226 DOI: 10.1096/fj.202002712RR] [Reference Citation Analysis]
13 Kunze J, Fritsch S, Peine A, Maaßen O, Marx G, Bickenbach J. Management of ARDS: From ventilation strategies to intelligent technical support – Connecting the dots. Trends in Anaesthesia and Critical Care 2020;34:50-8. [DOI: 10.1016/j.tacc.2020.05.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Swelum AA, Shafi ME, Albaqami NM, El-Saadony MT, Elsify A, Abdo M, Taha AE, Abdel-Moneim AE, Al-Gabri NA, Almaiman AA, Saleh Al-Wajeeh A, Tufarelli V, Staffa VN, Abd El-Hack ME. COVID-19 in Human, Animal, and Environment: A Review. Front Vet Sci 2020;7:578. [PMID: 33102545 DOI: 10.3389/fvets.2020.00578] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
15 Kressin C, Thompson Bastin M, Ather A, Gopinath A, Srour H, Schadler A, Pandya K. Cisatracurium Continuous Infusion Versus No Neuromuscular Blockade for Acute Respiratory Distress Syndrome on Venovenous Extracorporeal Membrane Oxygenation. J Clin Pharmacol 2021. [PMID: 34180067 DOI: 10.1002/jcph.1933] [Reference Citation Analysis]
16 Michalski JE, Kurche JS, Schwartz DA. From ARDS to pulmonary fibrosis: the next phase of the COVID-19 pandemic? Transl Res 2021:S1931-5244(21)00243-7. [PMID: 34547499 DOI: 10.1016/j.trsl.2021.09.001] [Reference Citation Analysis]
17 Ichikado K, Kawamura K, Johkoh T, Fujimoto K, Shintani A, Hashimoto S, Eguchi Y, Yasuda Y, Anan K, Shingu N, Sakata Y, Hisanaga J, Nitawaki T, Iio M, Sekido Y, Nishiyama K, Nakamura K, Suga M, Ichiyasu H, Sakagami T. Clinical phenotypes from fatal cases of acute respiratory distress syndrome caused by pneumonia. Sci Rep 2021;11:20051. [PMID: 34625618 DOI: 10.1038/s41598-021-99540-1] [Reference Citation Analysis]
18 Nirvik P, Kertai MD. Future of Perioperative Precision Medicine: Integration of Molecular Science, Dynamic Health Care Informatics, and Implementation of Predictive Pathways in Real Time. Anesth Analg 2022;134:900-8. [PMID: 35320133 DOI: 10.1213/ANE.0000000000005966] [Reference Citation Analysis]
19 Rizzo AN, Schmidt EP. ABO blood type: a window into the genetics of acute respiratory distress syndrome susceptibility. J Clin Invest 2021;131:144075. [PMID: 33141764 DOI: 10.1172/JCI144075] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Schwager E, Jansson K, Rahman A, Schiffer S, Chang Y, Boverman G, Gross B, Xu-Wilson M, Boehme P, Truebel H, Frassica JJ. Utilizing machine learning to improve clinical trial design for acute respiratory distress syndrome. NPJ Digit Med 2021;4:133. [PMID: 34504281 DOI: 10.1038/s41746-021-00505-5] [Reference Citation Analysis]
21 Meyer NJ, Gattinoni L, Calfee CS. Acute respiratory distress syndrome. Lancet 2021;398:622-37. [PMID: 34217425 DOI: 10.1016/S0140-6736(21)00439-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Huang CT, Liu KD. Exciting developments in the field of acute kidney injury. Nat Rev Nephrol 2020;16:69-70. [PMID: 31848461 DOI: 10.1038/s41581-019-0241-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Coppola S, Pozzi T, Gurgitano M, Liguori A, Duka E, Bichi F, Ciabattoni A, Chiumello D. Radiological pattern in ARDS patients: partitioned respiratory mechanics, gas exchange and lung recruitability. Ann Intensive Care 2021;11:78. [PMID: 33999274 DOI: 10.1186/s13613-021-00870-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Zhan Z, Cai H, Cai H, Liang X, Lai S, Luo Y. Effects of 45° prone position ventilation in the treatment of acute respiratory distress syndrome: A protocol for a randomized controlled trial study. Medicine (Baltimore) 2021;100:e25897. [PMID: 34106648 DOI: 10.1097/MD.0000000000025897] [Reference Citation Analysis]
25 Thompson Bastin ML, Smith RR, Bissell BD, Wolf HN, Wiegand AM, Cavagnini ME, Ahmad Y, Flannery AH. Comparison of fixed dose versus train-of-four titration of cisatracurium in acute respiratory distress syndrome. J Crit Care 2021;65:86-90. [PMID: 34118504 DOI: 10.1016/j.jcrc.2021.05.011] [Reference Citation Analysis]
26 Bo L, Jin F, Ma Z, Li C. Redox signaling and antioxidant therapies in acute respiratory distress syndrome: a systematic review and meta-analysis. Expert Rev Respir Med 2021;:1-11. [PMID: 33928830 DOI: 10.1080/17476348.2021.1924681] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Fröhlich E. Acute Respiratory Distress Syndrome: Focus on Viral Origin and Role of Pulmonary Lymphatics. Biomedicines 2021;9:1732. [PMID: 34829961 DOI: 10.3390/biomedicines9111732] [Reference Citation Analysis]
28 Rabi FA, Al Zoubi MS, Kasasbeh GA, Salameh DM, Al-Nasser AD. SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far. Pathogens. 2020;9. [PMID: 32245083 DOI: 10.3390/pathogens9030231] [Cited by in Crossref: 260] [Cited by in F6Publishing: 209] [Article Influence: 130.0] [Reference Citation Analysis]
29 Fatemi Y, Bergl PA. Diagnostic Stewardship: Appropriate Testing and Judicious Treatments. Crit Care Clin 2022;38:69-87. [PMID: 34794632 DOI: 10.1016/j.ccc.2021.09.002] [Reference Citation Analysis]
30 Reilly JP, Meyer NJ, Shashaty MG, Anderson BJ, Ittner C, Dunn TG, Lim B, Forker C, Bonk MP, Kotloff E, Feng R, Cantu E, Mangalmurti NS, Calfee CS, Matthay MA, Mikacenic C, Walley KR, Russell J, Christiani DC, Wurfel MM, Lanken PN, Reilly MP, Christie JD. The ABO histo-blood group, endothelial activation, and acute respiratory distress syndrome risk in critical illness. J Clin Invest 2021;131:139700. [PMID: 32931480 DOI: 10.1172/JCI139700] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 8.0] [Reference Citation Analysis]
31 Ruan SY, Huang CT, Chien YC, Huang CK, Chien JY, Kuo LC, Kuo PH, Ku SC, Wu HD. Etiology-associated heterogeneity in acute respiratory distress syndrome: a retrospective cohort study. BMC Pulm Med 2021;21:183. [PMID: 34059024 DOI: 10.1186/s12890-021-01557-9] [Reference Citation Analysis]
32 Abraham A, Krasnodembskaya A. Mesenchymal stem cell-derived extracellular vesicles for the treatment of acute respiratory distress syndrome. Stem Cells Transl Med. 2020;9:28-38. [PMID: 31647191 DOI: 10.1002/sctm.19-0205] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 18.0] [Reference Citation Analysis]
33 Zhang Y, Wang J, Liu YM, Yang H, Wu GJ, He XH. Analysis of the Efficacy and Mechanism of Action of Xuebijing Injection on ARDS Using Meta-Analysis and Network Pharmacology. Biomed Res Int 2021;2021:8824059. [PMID: 34124260 DOI: 10.1155/2021/8824059] [Reference Citation Analysis]
34 Song D, Zhao M, Feng L, Wang P, Li Y, Li W. Salidroside attenuates acute lung injury via inhibition of inflammatory cytokine production. Biomed Pharmacother 2021;142:111949. [PMID: 34325302 DOI: 10.1016/j.biopha.2021.111949] [Reference Citation Analysis]
35 Yang P, Esper AM, Martin GS. The Future of ARDS Biomarkers: Where Are the Gaps in Implementation of Precision Medicine? In: Vincent J, editor. Annual Update in Intensive Care and Emergency Medicine 2020. Cham: Springer International Publishing; 2020. pp. 91-100. [DOI: 10.1007/978-3-030-37323-8_7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Dong X, Zhu Z, Wei Y, Ngo D, Zhang R, Du M, Huang H, Lin L, Tejera P, Su L, Chen F, Ahasic AM, Thompson BT, Meyer NJ, Christiani DC. Plasma Insulin-like Growth Factor Binding Protein 7 Contributes Causally to ARDS 28-Day Mortality: Evidence From Multistage Mendelian Randomization. Chest 2021;159:1007-18. [PMID: 33189655 DOI: 10.1016/j.chest.2020.10.074] [Reference Citation Analysis]
37 Jabaudon M, Blondonnet R, Ware LB. Biomarkers in acute respiratory distress syndrome. Curr Opin Crit Care 2021;27:46-54. [PMID: 33278123 DOI: 10.1097/MCC.0000000000000786] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Soni S, Tirlapur N, O'Dea KP, Takata M, Wilson MR. Microvesicles as new therapeutic targets for the treatment of the acute respiratory distress syndrome (ARDS). Expert Opin Ther Targets 2019;23:931-41. [PMID: 31724440 DOI: 10.1080/14728222.2019.1692816] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
39 Lee J, Corl K, Levy MM. Fluid Therapy and Acute Respiratory Distress Syndrome. Crit Care Clin 2021;37:867-75. [PMID: 34548138 DOI: 10.1016/j.ccc.2021.05.012] [Reference Citation Analysis]